Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Kidney Int. 2017 Jul 6;92(4):864–875. doi: 10.1016/j.kint.2017.04.009

Figure 9. Summary figure of dietary effects on furosemide actions on urinary K excretion.

Figure 9

A. On CTRL diet, furosemide blocks NKCC2, inhibiting net K+ reabsorption in the TAL while increasing distal Na+ delivery and flow, which stimulates K+ secretion through ROMK and BK in ASDN. The net effect of furosemide is an increase in urinary K+ excretion. B. On LNaHK diet, up-regulated NKCC2 and ROMK, possibly by Ang II, results in net K+ secretion in the TAL. Elevated aldosterone (Aldo) from LNaHK upregulates ENaC, ROMK, and BK in the ASDN to promote distal K+ secretion. Furosemide blocks NKCC2, inhibiting net K+ secretion in the TAL. Although furosemide increases distal Na+ delivery and flow that stimulate K+ secretion in ASDN, the net result is a decrease in urinary K+ excretion. Transporters in the basolateral membrane and cell types of ASDN have been omitted for simplicity.